BioSpace News Archive

AbbVie announced the final results of its modified Dutch auction tender offer, which expired at 12:00 midnight, New York City time, at the end of May 29, 2018.

Leica Microsystems announces new market representation for its neurosurgical, spine, ophthalmic, otolaryngologic, dental and plastic reconstructive microscope sales in Southern California.

Burn Boot Camp, a nationwide health & fitness franchise teams up with the MDA for their third annual “Be Their Muscle” philanthropic event to benefit the MDA.

Eclipse has announced the formation of its Medical and Scientific Advisory Board (M&SAB) for 2018.

Merck KGaA, Darmstadt, Germany and Pfizer Inc. announced that updated efficacy and safety data from the pivotal JAVELIN Merkel 200 trial of BAVENCIO(R) (avelumab) in patients with metastatic Merkel cell carcinoma (mMCC), will be presented as an oral abstract session at the 54th American Society of Clinical Oncology (ASCO) Annual Meeting.

Eyecarrot Innovations Corp is pleased to announce its President and Co-founder Adam Cegielski will present at the annual LD Micro Invitational.

Array BioPharma Inc. announced updated results from the Phase 3 COLUMBUS trial in BRAF-mutant advanced melanoma.

MEI Pharma, Inc. announced that data presented at ASCO 2018 from an investigator-initiated study of ME-344 in patients with HER2 negative breast cancer demonstrate evidence of inhibition of tumor proliferation as measured by Ki-67 reductions.

HUYA Bioscience International (HUYA) announced it is at a key stage in the company’s development of HBI-8000, HUYA’s lead novel epigenetic drug with important immunomodulatory properties.

OncoSec Medical Incorporated announced the presentation of a Trials in Progress poster at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting taking place in Chicago, IL.